Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function.
about
Polymorphism of ORM1 is associated with the pharmacokinetics of telmisartanSelected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohortPolymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia.Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance.Urinary elimination of coproporphyrins is dependent on ABCC2 polymorphisms and represents a potential biomarker of MRP2 activity in humansEffect of ABCC2 (MRP2) transport function on erythromycin metabolismMultigene predictors of tacrolimus exposure in kidney transplant recipients.Efflux transporter variants as predictors of drug toxicity in lung cancer patients: systematic review and meta-analysis.ABCB1 and ABCC2 and the risk of distant metastasis in Thai breast cancer patients treated with tamoxifen.Genetic and biochemical study of dual hereditary jaundice: Dubin-Johnson and Gilbert's syndromes. Haplotyping and founder effect of deletion in ABCC2Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipientsAssociation of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifen.The effects of ABCC2 G1249A polymorphism on the risk of resistance to antiepileptic drugs: a meta-analysis of the literature.Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients.A systematic review and meta-analysis of the role of ABCC2 variants on drug response in patients with epilepsy.Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.ABCC2 (1249G > A) polymorphism implicates altered transport activity for sorafenib.In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants.Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study.Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy.Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease.Fexofenadine, a Putative In Vivo P-glycoprotein Probe, Fails to Predict Clearance of the Substrate Tacrolimus in Renal Recipients.Gender-Specific Association Between ABCC2 -24C>T SNP and Reduction in Triglycerides in Chilean Patients Treated With Atorvastatin.Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype.ABCC2 transporter gene polymorphisms, diet and risk of colorectal cancer: a Danish prospective cohort study.Lack of association between ABCC2 gene variants and treatment response in epilepsyAssociation of -24CT, 1249GA, and 3972CT ABCC2 Gene Polymorphisms with Methotrexate Serum Levels and Toxic Side Effects in Children with Acute Lymphoblastic Leukemia
P2860
Q28535089-E03F11BD-3F0C-4945-9151-EDB8A4F0F3D6Q28537826-E819EE2C-9DF8-49C0-82DC-BDFD29BFB8C2Q33395469-9680306D-CA1C-4957-96E8-543447295C29Q34065294-6507B32F-E89B-4C81-84F6-BDD9B0A2BBCDQ34897941-1AC5C03F-2AF1-4A55-B074-950DD1BC5D70Q35902300-9EDA2D85-859C-4147-8992-01917E7AB647Q35924246-AC91EBC6-650A-442E-A9FF-036FEC945752Q36043023-EEC2FDC7-4690-4179-8CE7-E39C0BFDAA5CQ36808170-79DEBB1D-818F-4060-ACDD-793E79A6B64AQ37058526-1E660745-4624-49A1-9A53-0BF76A5740CEQ37126092-D46BBF42-479C-4855-B619-7087B2C25269Q37140638-1C6C2185-B811-4859-BDB6-CDFD8249C38CQ37587940-E5D5FE2C-7861-406E-88FD-E4B6E8AE7CC4Q37641721-F896BDFC-DFAD-460D-A2F1-CFA7F9D491C8Q37688251-275B6815-9F9C-42F6-95B2-74905F0482A3Q38090733-941EC8CC-50D4-4E8A-A57C-BEB38A00BBAAQ38243832-D8D79029-FCCB-4637-B773-3410342779F2Q38730665-27A6C5BD-B0E9-4138-8520-6E4DD717FA6EQ38838936-240E3062-7F33-405E-B59C-173233C0E62CQ38896041-B1BDAFDA-6AA9-4A5C-BEF3-ECC4655BB793Q39337368-F522AF1A-8D49-4D12-8793-D5FDAAE63594Q41643368-4447D9AF-FA24-4603-A306-D76B74B70F44Q42722753-14C5DC46-6FA7-437D-B6DA-CA93BDF37EB1Q44363685-F598A67F-5C3C-4D61-BEE9-A8EA7E7B0BDDQ47303894-F2E6F70D-57D9-4AF2-B2BA-EAC08D333878Q47572522-2B6BACCC-CE3D-4F22-9A90-1EAD0AB90AAEQ48175100-BE1C4A4E-8A15-4F62-9DA3-E3579B953D78Q50555946-9C6CE330-EA8F-49FC-B9C5-DE5656AC6830Q58050207-799E09FE-4AD6-4A33-B2D5-BF4466F3DD51Q58924217-40EC093A-FE1C-45D5-806F-CCA426E76FB1
P2860
Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Impact of ABCC2 haplotypes on ...... gene regulation and function.
@en
Impact of ABCC2 haplotypes on ...... gene regulation and function.
@nl
type
label
Impact of ABCC2 haplotypes on ...... gene regulation and function.
@en
Impact of ABCC2 haplotypes on ...... gene regulation and function.
@nl
prefLabel
Impact of ABCC2 haplotypes on ...... gene regulation and function.
@en
Impact of ABCC2 haplotypes on ...... gene regulation and function.
@nl
P2093
P2860
P356
P1476
Impact of ABCC2 haplotypes on ...... l gene regulation and function
@en
P2093
A Ruehmkorf
S Haenisch
S Laechelt
W Siegmund
P2860
P2888
P356
10.1038/TPJ.2010.20
P577
2010-03-30T00:00:00Z